Dr. Freyja McClenahan

Freyja McClenahan, PhD, is a proficient medical writer at Oxford PharmaGenesis since January 2021, following a notable role as Impact Communications Officer - Research at Alzheimer's Society from November 2018 to December 2020, where contributions included providing dementia research content and leading funding proposals. Previous experience includes project management at The Pregnancy Pause, managing a research project at the University of Cambridge valued at £200,000, and significant early-career roles at Stony Brook University, where Freyja led research on forebrain stem cells and provided extensive teaching support. Educational credentials encompass a B.Sc. (Hons) in Neuroscience from UCL, a PhD in Neuroscience from Stony Brook University, and a postdoctoral research associate tenure at the University of Cambridge.